- Home
- FC vs VNDA Comparison
FC vs VNDA Comparison
Compare FC & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FC
- VNDA
- Stock Information
- Founded
- FC 1983
- VNDA 2002
- Country
- FC United States
- VNDA United States
- Employees
- FC N/A
- VNDA N/A
- Industry
- FC Other Consumer Services
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- FC Consumer Discretionary
- VNDA Health Care
- Exchange
- FC Nasdaq
- VNDA Nasdaq
- Market Cap
- FC 279.6M
- VNDA 237.9M
- IPO Year
- FC 1992
- VNDA 2006
- Fundamental
- Price
- FC $23.38
- VNDA $4.34
- Analyst Decision
- FC Strong Buy
- VNDA Strong Buy
- Analyst Count
- FC 2
- VNDA 3
- Target Price
- FC $42.50
- VNDA $15.33
- AVG Volume (30 Days)
- FC 77.0K
- VNDA 519.0K
- Earning Date
- FC 06-25-2025
- VNDA 05-07-2025
- Dividend Yield
- FC N/A
- VNDA N/A
- EPS Growth
- FC 8.95
- VNDA N/A
- EPS
- FC 1.34
- VNDA N/A
- Revenue
- FC $286,195,000.00
- VNDA $201,351,000.00
- Revenue This Year
- FC N/A
- VNDA $16.86
- Revenue Next Year
- FC $5.25
- VNDA $39.78
- P/E Ratio
- FC $17.41
- VNDA N/A
- Revenue Growth
- FC 2.53
- VNDA 13.37
- 52 Week Low
- FC $18.94
- VNDA $3.81
- 52 Week High
- FC $44.46
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- FC 54.57
- VNDA 51.79
- Support Level
- FC $22.65
- VNDA $4.17
- Resistance Level
- FC $23.82
- VNDA $4.41
- Average True Range (ATR)
- FC 0.65
- VNDA 0.16
- MACD
- FC 0.19
- VNDA 0.03
- Stochastic Oscillator
- FC 72.43
- VNDA 73.61
About FC Franklin Covey Company
Franklin Covey Co is a company focused on organizational performance improvement. It focuses on providing time management and effectiveness training for individuals and corporations via online training as well as in-person workshops and events. The company provides training and consulting services in the areas of leadership, execution, productivity, trust, sales performance, customer loyalty, and educational improvement. It operates in the business segments of Direct Offices, Education division, and International Licensees. The company derives revenue from providing training and consulting services, and through the selling of books, audio media, and other related products. It has a business presence in the Australia, New Zealand, China, Japan, United Kingdom, Ireland, and Other countries.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.